NF-κB has also been an important target for anti-cancer treatment and this study demonstrated that SF5 exposure inhibited NF-κB translocation to the nucleus, probably inhibiting the expression of specific NF-κB targets, as here demonstrated for cyclin E2 and c-myc. This evidence concerns the gene NFKB1 and cancer.